Comparative Biosciences, Inc
Our particular areas of expertise include ocular, dermatology, fibrosis, otic/ototoxicity, wound healing, burns, stem cells, oncology, renal, ophthalmology, inflammation, immune-mediated models, cardiovascular and pulmonary studies, and infection models and devices, as well as contract histopathology, immunohistochemistry and custom model development.
CBI is the industry leader in conducting difficult and unique IND-enabling research studies including those involving stem cells, stem cell and device combinations, delivery systems, diabetes and cancer therapies.
We have a fully staffed, state-of-the-art, AAALAC-accredited facility that is purpose-built with both an in-house histopathology laboratory and a full-time quality assurance unit. We are registered with the FDA, USDA and OLAW, and our clients range from small biomedical companies to pharmaceutical giants, academia, defense and government.
Offices in United States: